TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
SVRA

Savara Inc

Healthcare · Biotechnology

5.00$ -1.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow SVRA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-1,592,054.3% -61,016,666.7% -2,092.5% – – – -15,500.4% -4,008,100.0% – – – –
5,491.0% 270,370.4% 86.5% – – – 269.6% 36,700.0% – – – –
131,266.1% 4,953,703.7% 52.3% – – – 1,987.2% 326,000.0% – – – –
99,870.8% 4,964,814.8% 1,579.8% – – – 4,014.0% 486,000.0% – – – –
156,718.3% 7,187,037.0% 374.5% – – – -663.4% -284,600.0% – – – –
9,496.1% 305,555.6% 2.0% – – – 1,281.7% 5,700.0% – – – –
31,072.4% 6,287,037.0% -2.0% – – – 3,522.6% -6,945,600.0% – – – –
0.0% 0.0% 0.0% – – – 824.9% – – – – –
2,215,180.9% 3,700,000.0% 4,835.5% – – – 824.9% -7,800.0% – – – –
645,994.8% 27,407,407.4% -2,946.0% – – – -200.0% 0.0% – – – –
2,215,180.9% 31,107,407.4% 1,279.3% – – – 1,435.4% 12,080,600.0% – – – –
654,199.0% -23,622,222.2% -827.5% – – – -10,476.3% 1,113,200.0% – – – –
-1,601,550.4% -61,322,222.2% -2,094.5% – – – -16,782.1% -4,013,800.0% – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?